SCHEMBL9138993

SCHEMBL9138993

Nc1nnc(CCN2CCC(c3ccccc3)CC2)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.57
SLC18A3 Q16572 2/20 0.51
DRD2 P14416 1/20 0.51
SIGMAR1 Q99720 5/20 0.51
MEN1 O00255 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50
ATM Q13315 1/20 0.49
CHRNA7 P36544 2/20 0.48
CARM1 Q86X55 1/20 0.48
PRMT6 Q96LA8 1/20 0.48
GRIN2B Q13224 2/20 0.47
GRIN2A Q12879 1/20 0.46
GLS O94925 1/20 0.45
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7330036 0.99 L3MBTL1 (0.56) L3MBTL1SLC18A3DRD2SIGMAR1MEN1
Hydrochloric Acid SCHEMBL7323236 0.91 SIGMAR1 (0.58) L3MBTL1SLC18A3DRD2SIGMAR1MEN1
Hydrochloric Acid SCHEMBL7323559 0.79 GRIN2B (0.71) L3MBTL1SLC18A3DRD2SIGMAR1MEN1
Hydrochloric Acid SCHEMBL7326427 0.77 L3MBTL1 (0.58) L3MBTL1DRD2SIGMAR1MEN1CYP2D6
SCHEMBL9374358 0.74 SIGMAR1 (0.81) SLC18A3DRD2SIGMAR1MEN1TP53
SCHEMBL10360724 0.72 SLC18A3 (0.69) SLC18A3DRD2SIGMAR1MEN1TP53
SCHEMBL2400051 0.71 L3MBTL1 (0.71) L3MBTL1ATMGLSALDH1A1
Hydrochloric Acid SCHEMBL7318616 0.71 L3MBTL1 (0.53) L3MBTL1DRD2SIGMAR1CYP2D6TSHR
Hydrochloric Acid SCHEMBL9137258 0.71 L3MBTL1 (0.50) L3MBTL1DRD2SIGMAR1CYP3A4TSHR
SCHEMBL27542888 0.71 SIGMAR1 (0.66) SLC18A3SIGMAR1MEN1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5424312-A Treating central nervous system disorders, high blood pressure BASF AKTIENGESELLSCHAFT (DE) 1995-06-13 US disclosed